×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 2 - Fact of Central Monitoring
Session Chair(s)
Hiroshi Kosaku, MSc
Senior Corporate Officer, Non-clinical CRO Business, Bio-CDMO Business
CMIC HOLDINGS, Japan
Yukiko Nagata
Director, Biometrics
ICON Clinical Research GK, Japan
Speaker(s)
Our Challenges for Central Monitoring at Eli Lilly
Misato Kuwagaki, MS
Eli Lilly Japan K.K., Japan
Associate Director, Data Sciences
Turning Risk-Based Monitoring Challenges into Opportunities
Yumi Sugiura, MRCP
Bristol-Myers Squibb K.K., Japan
Global Clinical Operations, Global Data Management and Centralized Monitoring
Development and the Operation of Central Monitoring in Asian Trials
Yoji Shiobara, MPharm, RPh
IQVIA Services Japan K.K., Japan
Centralized Monitoring Manager
Technology Requirements and Challenges to Maximize Synergy of Central and Site Monitoring
Hiroshi Matsui
Medidata Solutions K.K., Japan
Client Services Principal, Professional Services
Have an account?